Condition
GEP-NET clinical trials and research
Research outlook What's coming for Neuroendocrine tumors: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 GEP-NET clinical trials that are recruiting, at sites in 3 countries (most in Italy (1), Canada (1), United States (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
RYZ401 for solid tumors that express somatostatin receptors
This trial will try RYZ401, a targeted radiotherapy, in adults with neuroendocrine or other solid tumors that show somatostatin receptors to find a safe dose and see if it shrinks tumors.
-
Examining factors affecting treatment response in gastroenteropancreatic neuroendocrine tumors
This study looks at how different factors related to tumors and patients affect how well treatments work for people with gastroenteropancreatic neuroendocrine tumors.
Related topics
Quick answers
How many GEP-NET clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Italy (1 trial), Canada (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.